Loading...

MET Pathway as a Therapeutic Target

Dysregulation of MET receptor tyrosine kinase pathway leads to cell proliferation, protection from apoptosis, angiogenesis, invasion and metastasis. It can be dysregulated via overexpression, constitutive activation, gene amplification, ligand-dependent activation or mutation. New drugs targeting va...

Full description

Saved in:
Bibliographic Details
Main Authors: Kim, Eric S., Salgia, Ravi
Format: Artigo
Language:Inglês
Published: 2009
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2664527/
https://ncbi.nlm.nih.gov/pubmed/19333071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31819d6f91
Tags: Add Tag
No Tags, Be the first to tag this record!